Latest American Medical Systems Stories

Results from Large Randomized Trial Support Use of Innovative 180 Watt Laser Therapy as a Viable Treatment Option for More Than 110 Million Men Worldwide with Enlarged Prostate MINNETONKA, Minn., May 6, 2013 /PRNewswire/ -- Data to be presented tomorrow at the American Urological Association (AUA) Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia (BPH) with GreenLight XPS(®) laser therapy with MoXy(®) fiber, instead of transurethral resection of the...

MALVERN, Pa., Feb. 28, 2013 /PRNewswire/ -- Total quarterly revenues of $801 million, comparable to prior year. Fourth quarter reported diluted (GAAP) loss per share of $6.35 includes a $640 million non-cash asset impairment charge related primarily to goodwill and other intangible assets attributable to the company's American Medical Systems (AMS) segment. Fourth quarter adjusted diluted EPS of $1.62 increased by 16 percent versus prior year; Full year 2012 adjusted diluted EPS...

CHADDS FORD, Pa., Jan. 3, 2013 /PRNewswire/ -- Reaffirms 2012 Adjusted Diluted EPS to be at or Below Low End of Previous Range of $5.00-$5.10 Company expects asset impairment and other charges to materially reduce reported diluted (GAAP) EPS in 2012 to amounts materially below previously announced guidance of $0.87 to $0.97 Provides 2013 Revenue Guidance Range of $2.80 Billion to $2.95 Billion and Adjusted Diluted EPS Range of $4.40 - $4.70 Endo Health Solutions (Nasdaq: ENDP)...

CHADDS FORD, Pa., Oct. 4, 2012 /PRNewswire-FirstCall/ -- Highlights long-term growth drivers and investment attributes of the company Endo updates 2012 performance, reaffirms full year 2012 revenues of $3.05 to $3.175 billion and adjusted diluted EPS in the range of $5.00 to $5.20; expects reported or GAAP diluted EPS of $1.37 to $1.57 Company expects 2013 revenue of $3.0 to $3.2 billion and adjusted diluted EPS of $5.20 to $5.40; expects reported or GAAP diluted EPS of $3.17 to...

MINNETONKA, Minn., Aug. 21, 2012 /PRNewswire/ -- American Medical Systems (AMS), an Endo Health Solutions (Nasdaq: ENDP) company and a leading provider of devices and therapies for male and female pelvic health, today introduced the new 650kJ MoXy(®) fiber for its class-leading GreenLight XPS(®) system for photoselective vaporization of the prostate. Providing more than 50 percent more energy than the previous fiber for the same price, the new MoXy fiber will enable physicians to...

Parker Waichman LLP has filed a lawsuit on behalf of a New York woman who suffered permanent and substantial injuries, allegedly due to the Gynecare Prolift Total Pelvic Floor Repair System and Miniarc Precise Sling transvaginal mesh implants. The lawsuit claims the Defendants put consumers at risk by marketing and selling the device, even though they were aware of the possibility of erosion and other serious complications. New York, NY (PRWEB) August 09, 2012 Parker Waichman LLP, a...

CHADDS FORD, Pa., Aug 7, 2012 /PRNewswire/ -- Total quarterly revenues of $785 million, increased 29 percent versus prior year Qualitest grows quarterly sales by 20 percent versus prior year Commercial conversion of OPANA(®) ER to new formulation designed to be crush-resistant completed during second quarter Company maintains adjusted diluted EPS in the range of $5.00 to $5.20; Now expects reported diluted (GAAP) EPS in the range of $1.07 to $1.27 Company now expects...

CHADDS FORD, Pa., July 18, 2012 /PRNewswire-FirstCall/ -- Endo Health Solutions (Nasdaq: ENDP) today announced the appointment of Camille Farhat to President of American Medical Systems (AMS), a wholly owned subsidiary of Endo Health Solutions. AMS, based in Minnetonka, Minn., is a leader in the supply of medical devices and procedures to treat incontinence, erectile dysfunction, benign prostatic hyperplasia (BPH) and other pelvic disorders for men and women. Prior to joining...

CHADDS FORD, Pa., June 7, 2012 /PRNewswire-FirstCall/ -- American Medical Systems (AMS), an Endo Health Solutions company (Nasdaq: ENDP), announced today it has signed a co-development agreement with Allergan, Inc. to jointly develop and seek regulatory approval for the delivery of BOTOX®( )(onabotulinumtoxinA) ( )using the JetTouch(TM) system for treatment of overactive bladder (OAB). AMS' JetTouch(TM) is a novel injection platform that has the potential to enable needle-free...

CHADDS FORD, Pa., March 29, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) announced today that American Medical Systems' (AMS) Group President, Tony Bihl, will step down as head of the Endo devices operating company in July 2012. While the company has not named a successor, a comprehensive executive search has been initiated. Mr. Bihl joined Endo as Group President in June 2011 with the acquisition of AMS and was named President and Chief Executive Officer of AMS in April 2008. About...